These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions. Iwamoto ET, Loh HH, Way EL. J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346 [Abstract] [Full Text] [Related]
3. Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum. Laschka E, Herz A, Bläsig J. Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):15-23. PubMed ID: 1034882 [Abstract] [Full Text] [Related]
5. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats. Cox B, Ary M, Lomax P. J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260 [Abstract] [Full Text] [Related]
7. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats. Ary M, Cox B, Lomax P. J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107 [Abstract] [Full Text] [Related]
8. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline. Way EL, Iwamoto ET, Khanna S, Ho IK, Shen F, Loh HH. J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429 [Abstract] [Full Text] [Related]
9. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice. Zarrindast MR, Mohajeri S. Eur J Pharmacol; 2006 Dec 15; 552(1-3):90-8. PubMed ID: 17049514 [Abstract] [Full Text] [Related]
10. Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment. Honkanen A, Piepponen TP, Ahtee L. Neurosci Lett; 1994 Oct 24; 180(2):119-22. PubMed ID: 7700562 [Abstract] [Full Text] [Related]
11. Changes in striatal dopamine metabolism during precipitated morphine withdrawal. Gramsch C, Bläsig J, Herz A. Eur J Pharmacol; 1977 Aug 01; 44(3):231-40. PubMed ID: 560969 [Abstract] [Full Text] [Related]
12. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions. Iwamoto ET, Loh HH, Way EL. Eur J Pharmacol; 1976 Jul 01; 38(1):39-54. PubMed ID: 986306 [Abstract] [Full Text] [Related]
13. The dynamics of hippocampal sensory gating during the development of morphine dependence and withdrawal in rats. Zheng J, Yang Y, Tian S, Chen J, Wilson FA, Ma Y. Neurosci Lett; 1976 Jul 01; 382(1-2):164-8. PubMed ID: 15911142 [Abstract] [Full Text] [Related]
14. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine. Smits SE. Res Commun Chem Pathol Pharmacol; 1975 Apr 01; 10(4):651-61. PubMed ID: 1171511 [Abstract] [Full Text] [Related]
15. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats. Iwamoto ET, Ho IK, Way EL. J Pharmacol Exp Ther; 1973 Dec 01; 187(3):588-67. PubMed ID: 4797745 [No Abstract] [Full Text] [Related]
16. The potentiation of morphine-withdrawal jumping by clonidine is antagonized by m-chlorophenylpiperazine and not by haloperidol. van der Laan JW, Hillen FC. Arch Int Pharmacodyn Ther; 1986 Sep 01; 283(1):45-55. PubMed ID: 2879519 [Abstract] [Full Text] [Related]
17. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal. Druhan JP, Walters CL, Aston-Jones G. J Pharmacol Exp Ther; 2000 Aug 01; 294(2):531-8. PubMed ID: 10900229 [Abstract] [Full Text] [Related]
18. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Rehni AK, Bhateja P, Singh TG, Singh N. Behav Pharmacol; 2008 May 01; 19(3):265-9. PubMed ID: 18469544 [Abstract] [Full Text] [Related]
19. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats. Wei XL, Su RB, Wu N, Lu XQ, Zheng JQ, Li J. Eur Neuropsychopharmacol; 2007 Dec 01; 17(12):790-9. PubMed ID: 17604969 [Abstract] [Full Text] [Related]